1. Introduction
===============

Rhabdomyosarcoma (RMS) is a rare malignancy that commonly occurs in childhood and constitutes more than 50% of all soft-tissue sarcomas. In contrast, RMS is exceedingly infrequent in adults; soft-tissue sarcomas make up less than 1% of all adult malignancies, and RMS accounts for 3% of all soft-tissue sarcomas.^\[[@R1]\]^ Moreover, the incidence of RMS of the liver is extremely low. Only 20 cases of RMS of the liver have been reported through 2017;^\[[@R2]--[@R18]\]^ the majority of these were embryonal, and 5 cases were pleomorphic RMS. These studies suggested that rupture and necrosis often occur in cases of hepatic RMS. RMS is difficult to manage because of its high malignancy rate and the absence of standard treatment guidelines due to its rarity. Here we present a special case of a 66-year-old woman eventually diagnosed as having a hepatic cyst with pleomorphic RMS, which was initially regarded as a simple hepatic cyst. This study proposes that timely and accurate diagnosis and aggressive treatment may help improve the prognosis for these patients.

2. Case presentation
====================

2.1. Patient information
------------------------

One month before admission to our department (a provincial hospital), a 66-year-old woman with a 5-year history of an abdominal mass was admitted to another county hospital with symptoms of aggravated epigastric pain for the past 10 days. In response to the manifestation of an upper abdominal mass and persistent pain due to distention of her abdomen, a computed tomography (CT) scan was performed (Fig. [1](#F1){ref-type="fig"}). A hepatic cyst partial resection of the right hepatic lobe and windowing decompression of the right anterior lobe were performed based on the diagnosis of a ruptured hepatic cyst. Postoperative histopathological analysis confirmed the initial diagnosis. However, following the operation, the patient still felt the abdominal distention and even increased; therefore, a percutaneous puncture was made to her pelvic cavity in an attempt to drain the ascites and hematomas, which alleviated distention slightly.

![Contrast-enhanced computed tomography (CT) performed at the patient\'s first hospital admission. (A, B) Shows a giant mass in the right lobe, considered to be a benign occupying lesion, most likely a ruptured, hemorrhaging cyst. CT = computed tomography.](medi-97-e11335-g001){#F1}

Next, the patient was transferred to our institution, with the diagnosis of cyst rupture and hemorrhage. An emergency physical examination revealed upper abdominal tenderness and distention, with a mass of approximately 20×20 cm, and pitting edema of the lower limbs. A faint yellow fluid was found in the puncture drainage tube from the pelvic cavity.

Ethical approval was not required, because this is an observational and descriptive study without interventions for control study. The patient and her guardians provided informed consent, and her individual anonymity was well protected.

2.2. Clinical findings
----------------------

Serum levels of alpha-fetoprotein (AFP) and AFP plastid ratio were within normal limits. Moreover, the following serum tumor markers were found: serum ferritin, 1,288.50 ng/mL; CA-125, 285.00 U/mL; CA-199, 55.82 U/mL, and CA-50, 68.52 U/mL. Contrast-enhanced CT scans of the abdomen and chest showed a 20×15 cm mass occupying the right lobe of the liver (Fig. [2](#F2){ref-type="fig"}).

![Computed tomography (CT) taken upon admission to our department showing a 20×15 cm extensive heterogeneous hypodense cystic lesion involving the right hepatic lobe, superior to the anterior edge of the liver. CT = computed tomography.](medi-97-e11335-g002){#F2}

2.3. Diagnostic assessment
--------------------------

Although the patient\'s first diagnosis was a hepatic cyst with rupture, hemorrhage, and infection, based on radiology findings and her history of surgeries, the initial diagnosis could not be completely accepted based on the size of the mass and the presence of serum tumor markers. Therefore, primary hepatocellular carcinoma, sarcoma, mesenchymal hamartoma, and secondary metastasis were considered. Positron emission tomography did not identify focal hypermetabolic lesions elsewhere in the body, and percutaneous biopsy was needed for a more definitive diagnosis.

2.4. Therapeutic interventions
------------------------------

Previous operations had not eliminated the abdominal mass completely, as evidenced by the aggravation of the patient\'s symptoms. Symptomatic treatments were administered to address her poor general condition before further examination was performed. An emergency laparotomy to effect hemostasis and a right hepatic lobectomy were performed to treat intra-abdominal hemorrhage 3 days after admission, without a pre-operative biopsy. Intraoperatively, about 1000 mL of cloudy hemorrhagic ascites was found in the abdominal cavity. A large high-pressure mass was found, which measured approximately 20×15 cm adhered tightly to the omentum, mesentery, and intestines anteriorly, and to the abdominal wall and diaphragm posteriorly. Cloudy brown fluid containing bile was extracted from the mass, which suggested that the mass was a hepatic cyst hydrops with hemorrhage and infection. Unfortunately, no intraoperative image was captured during the emergency surgery. Postoperative histopathological evaluation demonstrated loosely arranged, haphazardly oriented, large, round or pleomorphic cells with hyperchromatic and heteromorphic nuclei. Immunohistochemical analysis was positive for vimentin, desmin (Fig. [3](#F3){ref-type="fig"}), Ki-67, myosin, CD34 (vessel positive), and VIII factor (vessel positive), and negative for cytokeratin. Based on these findings, the diagnosis was established to be a hepatic cyst with RMS of the liver. Following the surgery, a percutaneous puncture was performed to drain the residual ascites and hematomas. A postoperative CT scan taken 18 days after the resection showed a heterogeneous hypodense cystic-solid lesion in the right subphrenic space and did not exclude the possibility of recurrence (Fig. [4](#F4){ref-type="fig"}). The patient and her guardians refused chemotherapy and other adjuvant therapies due to their passive view of disease and concerns about a low quality of life.

![Micrographs of pathologic and immunohistochemical analysis: Loosely arranged, haphazardly oriented, large, round or pleomorphic cells with hyperchromatic and heteromorphic nuclei (A). Identical pleomorphic tumor that stained positively for desmin by using immunohistochemistry (B).](medi-97-e11335-g003){#F3}

![Computed tomography (CT) taken 8 days after an emergency resection showing a heterogeneous hypodense cystic-solid lesion in the right subphrenic space, without excluding the possibility of recurrence. CT = computed tomography.](medi-97-e11335-g004){#F4}

2.5. Follow-up and outcomes
---------------------------

The patient was discharged from our hospital in relatively stable condition and turned to Chinese traditional medicine and herbs for treatment. She died approximately 141 days after her initial hospital admission for malnutrition and multiple organ failure. With respect to the disease presentation and the manifestations found in postoperative CT, we suspected that there was a great possibility of recurrence, even with metastasis; however, no autopsy was performed to ascertain this.

3. Discussion
=============

RMS is a rare malignancy. Age has been identified as an independent predictor of prognosis, with children \< 1 year and \>10 years-of-age having lower rates of survival.^\[[@R19]\]^ Childhood RMS occurs with a predilection for the head, neck, and genitourinary tracks, while adult RMS arises predominantly in the extremities.^\[[@R20]\]^ Embryonal RMS is the most common subtype of RMS in younger age groups; alveolar RMS is the most common subtype over the age of 10 years, and pleomorphic RMS is a disease of the elderly.^\[[@R18],[@R19]\]^ RMSs are uncommon in the liver; previously reported cases of liver RMS are summarized in Table [1](#T1){ref-type="table"} . These cases showed that RMSs in the liver are highly malignant with a very poor prognosis, even after surgery and/or chemotherapy.
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Pleomorphic RMS of the liver, as seen in the present case, is rare due to its presentation and the location of the neoplasms. Moreover, RMS of the liver usually manifests as a giant cystic or solid mass associated with rupture and hemorrhage, according to imaging examinations and/or intraoperative findings in previously reported cases.^\[[@R2]--[@R4],[@R14]--[@R16]\]^ Our patient was initially diagnosed with and treated for a hepatic cyst that had ruptured and hemorrhaged, and was infected. This was verified by the patient\'s first surgical procedure and histopathology testing performed before RMS was confirmed at our hospital. The diagnosis of hepatic cyst with RMS was supported by the long history of a stable abdominal mass and the histopathology findings. It is possible that RMS of the liver could have a long incubation period before the appearance of sudden enlargement, necrosis, rupture, or other severe symptoms; however, this possibility has not yet been reported; thus, this case provides important information. A limitation in the management of this case was the fact that no adjuvant chemotherapy was administered for further treatment.

Childhood RMS is a distinct entity that differs from typical adult soft-tissue sarcomas in terms of its natural course and its higher sensitivity to chemo- and radiotherapy. More than 70% of children with localized RMS can be cured with multidisciplinary treatment protocols that include chemotherapy.^\[[@R21]\]^ Gross total resection with negative margins, chemotherapy, and radiotherapy are recommended by the Intergroup Rhabdomyosarcoma Study Group and, together, is the generally accepted treatment protocol for childhood RMS. Surgical resection and radiotherapy are used for the management of the primary tumor site, while chemotherapy is used to prevent metastasis. Chemotherapeutic drugs that have been used to treat patients with RMS of the liver include vincristine, actinomycin-D, cyclophosphamide doxorubicin, ifosfamide, etoposide, and topotecan.^\[[@R2],[@R4],[@R13],[@R15],[@R17]\]^

RMSs in adults, especially those in the liver, are difficult to manage because of their rarity and the absence of a standard treatment protocol or guidelines. Standard treatments could be established, such as surgery, radiotherapy, and adjuvant chemotherapy with consideration given to the traditional treatment of childhood RMS. Surgery is a mainstay of treatment for pleomorphic RMS and has been correlated with an improved survival rate.^\[[@R22]\]^ Other studies have shown that the rate of response to chemotherapy in adults throughout the course of treatment is similar to that typically observed among children, and when adults are treated aggressively by using the pediatric protocol, the prognosis can be similar to that in children.^\[[@R2],[@R19]\]^ Some benefits resulting from adjuvant chemotherapy have been demonstrated in adults with soft-tissue sarcoma; however, the level of benefit has not been as high as that reported for children with RMS.^\[[@R23]\]^ We, therefore, suggest that adults and children with RMS should receive similar treatment, and that treatment protocols adopted from pediatric programs but tailored to adults could increase adults' chances of receiving appropriate and efficacious treatment.^\[[@R19]\]^

4. Conclusions
==============

RMS of the liver is a rare and highly malignant neoplasm with a poor prognosis, even after surgical and chemotherapy interventions, as is shown by the review of previously reported cases. However, we propose that early diagnosis, prompt and complete resection, and appropriate radiotherapy and chemotherapy are the keys to managing this disease and that these measures could prolong a patient\'s life. Similar measures have been successful in treating cases of RMS in children. In addition, from studying this rare case of RMS of the liver, we believe that this condition needs to be considered as a differential diagnosis when patients present with a ruptured hepatic mass. Moreover, appropriate preoperative imaging studies and percutaneous biopsy will be helpful for making this diagnosis. However, further studies are needed to develop the optimal treatment protocol for improving the prognosis of patients with this rare but deadly cancer.
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